MAPS Submits 2025 Cannabis Data Safety Update Report to FDA for MJP2 Phase 2 Study

On January 13, 2026, the Multidisciplinary Association for Psychedelic Studies (MAPS) submitted the 2025 Cannabis Data Safety Update Report (DSUR) to the U.S. Food and Drug Administration (FDA). The DSUR provides an annual safety update for the study in accordance with FDA expectations for ongoing clinical investigations. At the time of this submission, the Phase 2 study… Continue reading MAPS Submits 2025 Cannabis Data Safety Update Report to FDA for MJP2 Phase 2 Study